154 related articles for article (PubMed ID: 37257270)
1. Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities.
Shaker ME; Gomaa HAM; Abdelgawad MA; El-Mesery M; Shaaban AA; Hazem SH
Int Immunopharmacol; 2023 Jul; 120():110373. PubMed ID: 37257270
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.
Yang L; Seki E
Front Physiol; 2012; 3():138. PubMed ID: 22661952
[TBL] [Abstract][Full Text] [Related]
4. The contribution of sterile inflammation to the fatty liver disease and the potential therapies.
Shaker ME
Biomed Pharmacother; 2022 Apr; 148():112789. PubMed ID: 35272137
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
6. Role of spleen tyrosine kinase in liver diseases.
Kurniawan DW; Storm G; Prakash J; Bansal R
World J Gastroenterol; 2020 Mar; 26(10):1005-1019. PubMed ID: 32205992
[TBL] [Abstract][Full Text] [Related]
7. Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines.
Stephens LR; Anderson KE; Hawkins PT
J Biol Chem; 2001 Nov; 276(46):42767-73. PubMed ID: 11524430
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases.
Szilveszter KP; Németh T; Mócsai A
Front Immunol; 2019; 10():1862. PubMed ID: 31447854
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Src and Syk tyrosine kinases in HIV-1 transfer from dendritic cells to CD4+ T lymphocytes.
Gilbert C; Barat C; Cantin R; Tremblay MJ
J Immunol; 2007 Mar; 178(5):2862-71. PubMed ID: 17312130
[TBL] [Abstract][Full Text] [Related]
10. New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials.
Qu K; Huang Z; Lin T; Liu S; Chang H; Yan Z; Zhang H; Liu C
Front Pharmacol; 2015; 6():300. PubMed ID: 26834633
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors: a new approach for asthma.
Wong WS; Leong KP
Biochim Biophys Acta; 2004 Mar; 1697(1-2):53-69. PubMed ID: 15023350
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis.
Charan HV; Dwivedi DK; Khan S; Jena G
Genes Dis; 2023 Mar; 10(2):480-494. PubMed ID: 37223529
[TBL] [Abstract][Full Text] [Related]
13. Targeting the SYK-BTK axis for the treatment of immunological and hematological disorders: recent progress and therapeutic perspectives.
Tan SL; Liao C; Lucas MC; Stevenson C; DeMartino JA
Pharmacol Ther; 2013 May; 138(2):294-309. PubMed ID: 23396081
[TBL] [Abstract][Full Text] [Related]
14. Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
Palumbo T; Nakamura K; Lassman C; Kidani Y; Bensinger SJ; Busuttil R; Kupiec-Weglinski J; Zarrinpar A
Transplantation; 2017 Feb; 101(2):322-331. PubMed ID: 27820779
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis of hepatic stellate cells mediated by specific protein nitration.
Mòdol T; Natal C; Pérez de Obanos MP; Domingo de Miguel E; Iraburu MJ; López-Zabalza MJ
Biochem Pharmacol; 2011 Feb; 81(3):451-8. PubMed ID: 21056031
[TBL] [Abstract][Full Text] [Related]
16. Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors.
Singer CF; Hudelist G; Lamm W; Mueller R; Czerwenka K; Kubista E
Endocr Relat Cancer; 2004 Dec; 11(4):861-9. PubMed ID: 15613459
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease.
Beyer C; Distler JH
Biochim Biophys Acta; 2013 Jul; 1832(7):897-904. PubMed ID: 22728287
[TBL] [Abstract][Full Text] [Related]
18. Signaling network of the Btk family kinases.
Qiu Y; Kung HJ
Oncogene; 2000 Nov; 19(49):5651-61. PubMed ID: 11114746
[TBL] [Abstract][Full Text] [Related]
19. Pattern-recognition receptors in endometriosis: A narrative review.
Guo B; Chen JH; Zhang JH; Fang Y; Liu XJ; Zhang J; Zhu HQ; Zhan L
Front Immunol; 2023; 14():1161606. PubMed ID: 37033937
[TBL] [Abstract][Full Text] [Related]
20. Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
Torres-Hernandez A; Wang W; Nikiforov Y; Tejada K; Torres L; Kalabin A; Wu Y; Haq MIU; Khan MY; Zhao Z; Su W; Camargo J; Hundeyin M; Diskin B; Adam S; Rossi JAK; Kurz E; Aykut B; Shadaloey SAA; Leinwand J; Miller G
Oncogene; 2019 Jun; 38(23):4512-4526. PubMed ID: 30742098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
